Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) EBT (2016 - 2025)

Prestige Consumer Healthcare has reported EBT over the past 16 years, most recently at $61.8 million for Q4 2025.

  • Quarterly results put EBT at $61.8 million for Q4 2025, down 22.88% from a year ago — trailing twelve months through Dec 2025 was $266.7 million (down 3.92% YoY), and the annual figure for FY2025 was $284.2 million, up 2.96%.
  • EBT for Q4 2025 was $61.8 million at Prestige Consumer Healthcare, down from $69.1 million in the prior quarter.
  • Over the last five years, EBT for PBH hit a ceiling of $80.2 million in Q4 2024 and a floor of -$299.5 million in Q1 2023.
  • Median EBT over the past 5 years was $67.7 million (2022), compared with a mean of $48.1 million.
  • Biggest five-year swings in EBT: crashed 591.3% in 2023 and later soared 122.48% in 2024.
  • Prestige Consumer Healthcare's EBT stood at $65.5 million in 2021, then rose by 4.01% to $68.1 million in 2022, then grew by 2.14% to $69.6 million in 2023, then grew by 15.21% to $80.2 million in 2024, then decreased by 22.88% to $61.8 million in 2025.
  • The last three reported values for EBT were $61.8 million (Q4 2025), $69.1 million (Q3 2025), and $61.8 million (Q2 2025) per Business Quant data.